The objective of the study was to synthesize and to uncover the potentially interesting biological Radiant heat tail-flick test was used to observe the central analgesic activity which showed analgesic effect evidenced by % elongation time (34.59%, 25.34% and 53.08%), respectively compared to that of morphine 2 mg/kg body weight at an equimolar dose of tolfenamic acid at 10 mg/kg body weight after 30 minutes. In the final analysis, it can be stipulated that newly synthesized stable metal complexes of tolfenamic acid have promising pharmacological effects like peripheral and central analgesic potency. Therefore, these complexes may be the better therapeutic options in the near future however it needs further extensive analysis in the pharmacokinetics, pharmacodynamics and toxicology perspective.
INTRODUCTION
Non-steroidal anti-inflammatory drugs (NSAIDs) are also known as non-steroidal antiinflammatory agents/analgesics (NSAIAs) or nonsteroidal anti-inflammatory medicines (NSAIMs). These drugs have proved to be effective in the treatment of acute and chronic painful and inflammatory musculoskeletal conditions. 1 Tolfenamic acid i.e., 2-[bis (3-chloro-2-methylphenyl)-amino] benzoic acid or Htolf is a potent, well-tolerated NSAID with anti-inflammatory, analgesic and antipyretic effects. 
Tolfenamic acid
Tolfenamic acid acts by inhibiting prostaglandin and leukotriene synthesis. It is used to treat the symptoms of migraine. Chemically, it resembles mefenamic and flufenamic acids, other fenamates in clinical use. Tolfenamic acid inhibits COX-2 pathway preferentially. 2 Recent studies revealed that, in addition to arthritis and pain, cancer and neurodegenerative diseases like Alzheimer's disease could potentially be treated with COX-2 inhibitors. Tolfenamic acid selectively inhibits COX-2 pathway to exert its antiinflammatory, analgesic and antipyretic effects.
The undertaken study was focused on the synthesis of some novel metal complexes (Cu, Co and Zn complexes) of tolfenamic acid to screen better pharmacological profile compared to parent drug and also to investigate peripheral and central analgesic activities of metal complexes of tolfenamic acid. Experimental animals. Adult Swiss-albino mice 25-30 g ages of 4-5 week were used as experimental animal. They were housed properly and kept under well controlled temperature with humidity of 60-70% in the animal house and kept before the test for 5-7 days because of their environmental sensitivity.
MATERIALS AND METHODS

Drugs
Instrumental measurements. FT-IR Spectra were analyzed with FT-IR 8400S Shimadzu, Japan, spectrophotometer within the range 4000-400 cm -1 to determine the functional groups. A Shimadzu Model-UV-1800 spectrophotometer was used to observe UV-Vis spectra of tolfenamic acid and its metal complexes. DSC is a thermo-analytical measurement technique and was performed by DSC-60 WS, Shimadzu, Japan furnished with computer and convenient software program. 4 Peripheral analgesic activity. Peripheral analgesic activity can be evaluated by acetic acidinduced Writhing method. 5 Acetic acid was administered intra-peritoneally to the experimental animals to create pain sensation. As a result, the animals squirms their body at regular interval out of pain. This squirm or contraction of the body is termed as "writhing". As long as the animals feel pain, they continue to give writhing. Each writhing is counted and taken as an indication of pain sensation. Any substance that has got analgesic activity is supposed to lessen the number of writhing of animals within in a given time frame and with respect to the control group. The writhing inhibition of positive control was taken as standard and compared with test samples and control. As positive control, any standard NSAID drug can be used. In the present study, tolfenamic acid was used as a standard drug. The test was performed by taking samples at doses of 25 mg/kg body weight. The degree of analgesia or the percentage of inhibition of writhing was calculated by using the following formula:
(Mean of control group -Mean of treated group)/ Mean of control group × 100.
The result of statistical analysis for animal experiment were expressed as mean ± SEM; n=5 considering 95% confidence level at p<0.05 being considered as significant.
Central analgesic activity. Tail flick assay of animal models was used to determine central analgesic response. 6 A hot wire was applied to mice tail, which acted as pain stimulus. When the stimulus exceeded the threshold, rat showed instant withdrawal of its tail. 7 In this experiment, test samples and saline were administrated orally. The central analgesic activity of the test samples were compared in respect to morphine. Statistical analysis was done using Statistical Package for Social Science (SPSS) software by one-way ANOVA considering 95% confidence level at p<0.05 being considered as significant.
Statistical analysis. Statistical analyses were done by using the Statistical Package for Social Science version (SPSS)16.0 software, and statistical differences between groups were analyzed by oneway analysis of variance ANOVA followed by Dunnet t-tests. Data's were represented as means ± SEM and differences were considered statistically significant at p<0.05.
RESULTS AND DISCUSSION
An entrenched method which was slightly modified to prepare the metal complexes of tolfenamic acid was followed which was more economical. 8 The metal complexes of tolfenamic acid were characterized by both spectral and physicochemical analysis.
FTIR.
From the IR spectra of the synthesized metal complexes showed a characteristic bands of absorption by which they were identified. 9 As the carboxyl H-atom is more acidic than the amino Hatom the deprotonation occurs in the COOH group. This is confirmed by the IR spectra of the complexes, showing the characteristic bands for the secondary amino groups and for the coordinated carboxylate group. A broad absorption at 3600-3400 cm UV. Tolfenamic acid and its metal complexes were mixed in chloroform solution and UV-visible light was introduced set at 200 -400 nm range to observe characteristic absorbance. By observing the ultraviolet spectra of tolfenamic acid and its metal complexes revealed that there was clear hypochromic shift given in figure 2 . The respective absorbance of tolfenamic acid and its complexes are shown in table 2. All three metal complexes (Cu, Co and Zn) showed hypsochromic shift from parent tolfenamic acid. Tolfenamic acid and its complexes showed peaks of different intensity in the same wavelength, which supported the formation of complexes.
DSC. DSC is an established method for the analysis of synthetic drugs. There was a detectable change in the melting point of the complexes of tolfenamic acid compared with parent tolfenamic Central analgesic activity. The central analgesic activities of metal complexes of tolfenamic acid in tail flick method are given in table 4. In this experiment, metal complexes were given at an equimolar dose of tolfenamic acid at 10 mg/kg body weight individually. Cu, Co and Zn complexes of tolfenamic acid (with % elongation time of 34.59%, 25.34% and 53.08%, respectively) showed significant analgesic effect compared to that of morphine (2 mg/kg body weight) at an equimolar dose of tolfenamic acid at 10 mg/kg body weight after 30 minutes.
CONCLUSION
Scanty level of pharmacological investigation on divalent metal complexes of tolfenamic acid was a key driver to design our study and to search for new pharmacological properties such as peripheral and central analgesic potency; to prepare new compounds, i.e., complexes of tolfenamic acid with essential metal ions, which probably would exhibit improved or different biological properties compared to the parent NSAID. The Co and Zn complexes of tolfenamic acid possess considerably better analgesic potency than the parent tolfenamic acid and further bioactivity guided investigation can lead to the development of new classes of analgesic drugs.
